Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, Charles A. Gersbach
{"title":"Epigenome editing technologies for discovery and medicine","authors":"Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, Charles A. Gersbach","doi":"10.1038/s41587-024-02320-1","DOIUrl":null,"url":null,"abstract":"Epigenome editing has rapidly evolved in recent years, with diverse applications that include elucidating gene regulation mechanisms, annotating coding and noncoding genome functions and programming cell state and lineage specification. Importantly, given the ubiquitous role of epigenetics in complex phenotypes, epigenome editing has unique potential to impact a broad spectrum of diseases. By leveraging powerful DNA-targeting technologies, such as CRISPR, epigenome editing exploits the heritable and reversible mechanisms of epigenetics to alter gene expression without introducing DNA breaks, inducing DNA damage or relying on DNA repair pathways. Epigenome editing has versatile applications in biomedical research and disease treatment.","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"42 8","pages":"1199-1217"},"PeriodicalIF":33.1000,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature biotechnology","FirstCategoryId":"5","ListUrlMain":"https://www.nature.com/articles/s41587-024-02320-1","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Epigenome editing has rapidly evolved in recent years, with diverse applications that include elucidating gene regulation mechanisms, annotating coding and noncoding genome functions and programming cell state and lineage specification. Importantly, given the ubiquitous role of epigenetics in complex phenotypes, epigenome editing has unique potential to impact a broad spectrum of diseases. By leveraging powerful DNA-targeting technologies, such as CRISPR, epigenome editing exploits the heritable and reversible mechanisms of epigenetics to alter gene expression without introducing DNA breaks, inducing DNA damage or relying on DNA repair pathways. Epigenome editing has versatile applications in biomedical research and disease treatment.
表观基因组编辑近年来发展迅速,其应用领域多种多样,包括阐明基因调控机制、注释编码和非编码基因组功能以及编程细胞状态和品系规范。重要的是,由于表观遗传学在复杂表型中的作用无处不在,表观基因组编辑具有影响多种疾病的独特潜力。通过利用 CRISPR 等强大的 DNA 靶向技术,表观基因组编辑利用了表观遗传学的可遗传和可逆机制来改变基因表达,而无需引入 DNA 断裂、诱导 DNA 损伤或依赖 DNA 修复途径。
期刊介绍:
Nature Biotechnology is a monthly journal that focuses on the science and business of biotechnology. It covers a wide range of topics including technology/methodology advancements in the biological, biomedical, agricultural, and environmental sciences. The journal also explores the commercial, political, ethical, legal, and societal aspects of this research.
The journal serves researchers by providing peer-reviewed research papers in the field of biotechnology. It also serves the business community by delivering news about research developments. This approach ensures that both the scientific and business communities are well-informed and able to stay up-to-date on the latest advancements and opportunities in the field.
Some key areas of interest in which the journal actively seeks research papers include molecular engineering of nucleic acids and proteins, molecular therapy, large-scale biology, computational biology, regenerative medicine, imaging technology, analytical biotechnology, applied immunology, food and agricultural biotechnology, and environmental biotechnology.
In summary, Nature Biotechnology is a comprehensive journal that covers both the scientific and business aspects of biotechnology. It strives to provide researchers with valuable research papers and news while also delivering important scientific advancements to the business community.